MARSHALL & POPP, LLC for JAZZ PHARMACEUTICALS, INC. AND ITS SUBSIDIARIES, INCLUDING GREENWICH BIOSCIENCES
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Banking BAN
Issues related to the definition of "business of insurance". H.R.1595: Secure And Fair Enforcement Banking Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAZEN CLAY MARSHALL | — |
| MONICA POPP | — |
Health Issues HCR
Issues related to the Food and Drug Administration. H.R.3164/S.2522: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020. H.R.3055/S.2584: Commerce, Justice, Science Appropriations Act for FY 2020. H.R.2740: Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020. H.R.1865: Further Consolidated Appropriations Act, 2020. H.R.1158: Consolidated Appropriations Act, 2020. Issues related to enforcement of cannabis laws and cannabis research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAZEN CLAY MARSHALL | Policy Director-Senate Majority Leader Mitch McConnell; Staff Director/Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles |
| MONICA POPP | Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.